2019 国际共识声明:剖腹产期间宫缩剂的应用

2019-07-15 国外麻醉相关专家组(统称) Anaesthesia. 2019 Jul 25.

剖宫产时,新生儿出生后常规应用缩宫素。但是在相关的研究中却存在较大的异质性。本文主要针对剖腹产期间宫缩剂的应用提出共识指导。

中文标题:

2019 国际共识声明:剖腹产期间宫缩剂的应用

英文标题:

International consensus statement on the use of uterotonic agents during caesarean section.

发布日期:

2019-07-15

简要介绍:

剖宫产时,新生儿出生后常规应用缩宫素。但是在相关的研究中却存在较大的异质性。本文主要针对剖腹产期间宫缩剂的应用提出共识指导。 

拓展指南:剖腹产相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 国际共识声明:剖腹产期间宫缩剂的应用)] GetToolGuiderByIdResponse(projectId=1, id=a35511c001e731dd, title=2019 国际共识声明:剖腹产期间宫缩剂的应用, enTitle=International consensus statement on the use of uterotonic agents during caesarean section., guiderFrom=Anaesthesia. 2019 Jul 25., authorId=null, author=, summary=剖宫产时,新生儿出生后常规应用缩宫素。但是在相关的研究中却存在较大的异质性。本文主要针对剖腹产期间宫缩剂的应用提出共识指导。 , cover=, journalId=null, articlesId=null, associationId=1382, associationName=国外麻醉相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 15 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>剖宫产时,新生儿出生后常规应用缩宫素。但是在相关的研究中却存在较大的异质性。本文主要针对剖腹产期间宫缩剂的应用提出共识指导。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>剖腹产</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=d8e791c001e022bb" title="2019 ACOG实践简报:剖腹产后经阴道分娩(No.205)" target=_blank>2019 ACOG实践简报:剖腹产后经阴道分娩(No.205)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=8cf411c00151e22f" title="2017 ACOG实践简报:剖腹产后经阴道分娩(No.184)" target=_blank>2017 ACOG实践简报:剖腹产后经阴道分娩(No.184)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%89%96%E8%85%B9%E4%BA%A7" target=_blank>有关剖腹产更多指南</a></ul>, tagList=[TagDto(tagId=1754, tagName=剖腹产), TagDto(tagId=92738, tagName=宫缩剂)], categoryList=[CategoryDto(categoryId=29, categoryName=麻醉疼痛科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14254, appHits=390, showAppHits=0, pcHits=11333, showPcHits=3810, likes=78, shares=8, comments=5, approvalStatus=1, publishedTime=Tue Jul 30 22:21:03 CST 2019, publishedTimeString=2019-07-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jul 30 22:21:03 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 06:09:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 国际共识声明:剖腹产期间宫缩剂的应用)])
2019 国际共识声明:剖腹产期间宫缩剂的应用
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=900631, encodeId=c4b2900631c9, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/1a51156222e74879a1d251f753297406/4f6af6abf9ce443da4493359ea984c1e.jpg, createdBy=2e685322441, createdName=墨香annie , createdTime=Thu Nov 19 21:46:06 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897179, encodeId=d3ba89e17972, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44312551426, createdName=125423ccm52暂无昵称, createdTime=Thu Nov 05 19:10:30 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891690, encodeId=0c6b891690e5, content=翻译, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Tue Oct 13 08:37:35 CST 2020, time=2020-10-13, status=1, ipAttribution=)]
    2020-11-19 墨香annie

    需要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=900631, encodeId=c4b2900631c9, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/1a51156222e74879a1d251f753297406/4f6af6abf9ce443da4493359ea984c1e.jpg, createdBy=2e685322441, createdName=墨香annie , createdTime=Thu Nov 19 21:46:06 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897179, encodeId=d3ba89e17972, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44312551426, createdName=125423ccm52暂无昵称, createdTime=Thu Nov 05 19:10:30 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891690, encodeId=0c6b891690e5, content=翻译, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Tue Oct 13 08:37:35 CST 2020, time=2020-10-13, status=1, ipAttribution=)]
    2020-11-05 125423ccm52暂无昵称

    非常好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=900631, encodeId=c4b2900631c9, content=需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200909/1a51156222e74879a1d251f753297406/4f6af6abf9ce443da4493359ea984c1e.jpg, createdBy=2e685322441, createdName=墨香annie , createdTime=Thu Nov 19 21:46:06 CST 2020, time=2020-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897179, encodeId=d3ba89e17972, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44312551426, createdName=125423ccm52暂无昵称, createdTime=Thu Nov 05 19:10:30 CST 2020, time=2020-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891690, encodeId=0c6b891690e5, content=翻译, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Tue Oct 13 08:37:35 CST 2020, time=2020-10-13, status=1, ipAttribution=)]
    2020-10-13 125958ecm25暂无昵称

    翻译

    0